Assessing adherence in Thai patients taking combination antiretroviral therapy

International Journal of STD and AIDS

Volumn 23, Issue 3, 2012, Pages 160-165

  Kerr, S J ^a,b   Avihingsanon, A ^a   Putcharoen, O ^c   Chetchotisakd, P ^d   Layton, M ^e   Ubolyam, S ^a   Ruxrungtham, K ^c,f   Cooper, D A ^b   Phanuphak, P ^c,f   Duncombe, C ^a,b  

^a THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d KHON KAEN UNIVERSITY   (Thailand)

^e KHON KAEN UNIVERSITY   (Thailand)

^f THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

Author keywords

Adherence; Antiretroviral therapy; Asia; HAART; HIV; Resource limited setting; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CENTER FOR ADHERENCE SUPPORT EVALUATION; COMBINATION CHEMOTHERAPY; FEMALE; HEALTH BEHAVIOR; HEALTH CARE PERSONNEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; RELIABILITY; RISK FACTOR; SCORING SYSTEM; SELF REPORT; SENSITIVITY AND SPECIFICITY; THAILAND; VIRUS LOAD; VISUAL ANALOG SCALE;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DEVELOPING COUNTRIES; DIAGNOSTIC SELF EVALUATION; DRUG MONITORING; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; THAILAND;

EID: 84860907905     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009152     Document Type: Article

References (32)

1. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30
2. Wood E, Hogg RS, Yip B, et al. The impact of adherence on CD4 cell count responses among HIV-infected patients. J Acquir Immune Defic Syndr 2004;35:261-68
3. Harrigan PR, Hogg RS, Dong WW, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis 2005;191:339-47
4. Thai Ministry of Public Health. National Guidelines for the Clinical Management of HIV Infection in Children and Adults. Nonthaburi, Thailand: Ministry of Public Health, 2007
5. Fletcher CV, Testa MA, Brundage RC, et al. Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359. J Acquir Immune Defic Syndr 2005;40:301-06
6. Mannheimer S, Friedland G, Matts J, et al. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis 2002;34:1115-21
7. Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006;296:679-90
8. Maneesriwongul WL, Tulathong S, Fennie KP, Williams AB. Adherence to antiretroviral medication among HIV-positive patients in Thailand. J Acquir Immune Defic Syndr 2006;43(Suppl 1):S119-22
9. Giordano TP, Guzman D, Clark R, et al. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials 2004;5:74-79
10. Oyugi JH, Byakika-Tusiime J, Charlebois ED, et al. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr 2004;36:1100-02
11. Simoni JM, Kurth AE, Pearson CR, et al. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav 2006;10:227-45
12. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000;12:255-66
13. Mannheimer SB, Mukherjee R, Hirschhorn LR, et al. The CASE adherence index: a novel method for measuring adherence to antiretroviral therapy.AIDS Care 2006;18:853-61
14. Reynolds NR, Testa MA, Marc LG, et al. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study. AIDS Behav 2004;8:141-50
15. Gao X, Nau DP. Congruence of three self-report measures of medication adherence among HIV patients. Ann Pharmacother 2000;34:1117-22
16. Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr 2001;28:445-49
17. Altice FL, Mostashari F, Friedland GH. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr 2001;28:47-58
18. Duran S, Spire B, Raffi F, et al. Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clin Trials 2001;2:38-45
19. Holzemer WL, Corless IB, Nokes KM, et al. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDS 1999;13:185-97
20. Kumarasamy N, Safren SA, Raminani SR, et al. Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study. AIDS Patient Care STDS 2005;19:526-37
21. Wang H, He G, Li X, et al. Self-Reported adherence to antiretroviral treatment among HIV-infected people in Central China. AIDS Patient Care STDS 2008;22:71-80
22. National Statistical Office of Thailand. Household income, expenditure and debt. 2009. See http://web.nso.go.th/en/indicator/eco/ind_eco08.htm (last checked 23 March 2009)
23. CIA World Factbook. Thailand, 2008. See https://www.cia.gov/library/publications/the-world-factbook/geos/th.html (last checked 6 May 2009)
24. Miller LG, Golin CE, Liu H, et al. No evidence of an association between transient HIV viremia ('Blips') and lower adherence to the antiretroviral medication regimen. J Infect Dis 2004;189:1487-96
25. Shuter J. Forgiveness of non-adherence to HIV-1 antiretroviral therapy. J Antimicrob Chemother 2008;61:769-73
26. Melbourne KM, Geletko SM, Brown SL, et al. Medication adherence in patients with HIV infection: a comparison of two measurement methods. AIDS Read 1999;9:329-38
27. McCarthy EA, O'Brien ME, Rodriguez WR. Training and HIV-treatment scale-up: establishing an implementation research agenda. PLoS Med 2006;3:e304
28. Heckman BD, Catz SL, Heckman TG, et al. Adherence to antiretroviral therapy in rural persons living with HIV disease in the United States. AIDS Care 2004;16:219-30
29. Ingersoll KS, Heckman CJ. Patient-clinician relationships and treatment system effects on HIV medication adherence. AIDS Behav 2005;9:89-101
30. Munro SA, Lewin SA, Smith HJ, et al. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med 2007;4:e238
31. UNAIDS. Reducing stigma and discrimination: a critical part of national AIDS programmes: a resource for national stakeholders in the HIV response. Geneva: Joint United Nations Programme on HIV/AIDS, 2007
32. Hardon A, Hodgkin C, Fresle D. How to Investigate the Use of Medicines by Consumers. Geneva, Switzerland: World Health Organisation and University of Amsterdam, 2004